Report Scope & Overview:
Approved COVID-19 Vaccines Market size was valued at USD 6.25 Billion in 2021 and is projected to reach USD 10.79 Billion by 2030, growing at a CAGR of 7.16% from 2023 to 2030.
Approved COVID-19 Vaccines Market Overview:
Global Approved COVID-19 Vaccines Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. Approved COVID-19 Vaccines Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
Overall, Approved COVID-19 Vaccines market plays a crucial role in helping businesses and organizations make informed decisions based on data-driven insights. As the demand for data-driven decision-making continues to grow, Approved COVID-19 Vaccines market research is expected to experience further growth and innovation in the coming years.
Global Approved COVID-19 Vaccines Market: By Company
• Moderna
• CanSino Biologicals
• Inovio Pharmaceuticals
• Shenzhen Geno-Immune Medical Institute
• GlaxoSmithKine
• Pfizer
• Johnson＆Johnson
• Heat Biologics
• Sanofi
Global Approved COVID-19 Vaccines Market: By Type
• Component Viral Vaccines
• Whole Virus Vaccines
Global Approved COVID-19 Vaccines Market: By Application
• Adults
• Children
• Elderly
Global Approved COVID-19 Vaccines Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Approved COVID-19 Vaccines market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
Reasons to Purchase Approved COVID-19 Vaccines Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Overall, market research reports provide businesses and organizations with valuable information that can help them make informed decisions and stay competitive in their industry. They can provide a solid foundation for business planning, strategy development, and decision-making.
Objectives of Approved COVID-19 Vaccines Market Study:
The objectives of Approved COVID-19 Vaccines market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Approved COVID-19 Vaccines market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Overall, the objectives of Approved COVID-19 Vaccines market research report are to provide businesses and organizations with valuable insights and data-driven recommendations that can help them make informed business decisions and stay competitive in their industry.
Global Approved COVID-19 Vaccines Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. Approved COVID-19 Vaccines Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
Overall, Approved COVID-19 Vaccines market plays a crucial role in helping businesses and organizations make informed decisions based on data-driven insights. As the demand for data-driven decision-making continues to grow, Approved COVID-19 Vaccines market research is expected to experience further growth and innovation in the coming years.
Approved COVID-19 Vaccines Market Key Trends
Vaccine Development Speed: Unprecedented speed in the development and approval of COVID-19 vaccines, with several vaccines receiving Emergency Use Authorizations (EUAs) and full approvals in record time.
Diverse Vaccine Technologies: A wide range of vaccine technologies, including mRNA vaccines (e.g., Pfizer-BioNTech, Moderna), viral vector vaccines (e.g., Johnson & Johnson, AstraZeneca), and protein subunit vaccines (e.g., Novavax), contributing to a diverse vaccine portfolio.
Booster Shots and Variants: The development and distribution of booster shots to address waning immunity and new variants of the virus, with updated vaccines targeting specific variants.
Global Vaccine Equity: Efforts to ensure equitable access to vaccines worldwide, including initiatives like COVAX, to address vaccine distribution disparities and enhance global vaccination rates.
Vaccine Passports: The emergence of vaccine passports or certificates, digital or paper-based, to facilitate international travel and access to various activities and services.
Vaccine Hesitancy: Challenges related to vaccine hesitancy and misinformation, prompting public health campaigns to educate and encourage vaccination.
Pediatric Vaccination: The authorization and distribution of vaccines for children and adolescents, expanding the eligible population for vaccination.
Storage and Distribution Innovations: Innovations in vaccine storage and distribution, including ultra-cold storage solutions for mRNA vaccines and decentralized vaccination centers.
Adaptive Clinical Trials: Ongoing adaptive clinical trials to assess vaccine safety and efficacy in different populations and age groups.
Market Segmentations:Global Approved COVID-19 Vaccines Market: By Company
• Moderna
• CanSino Biologicals
• Inovio Pharmaceuticals
• Shenzhen Geno-Immune Medical Institute
• GlaxoSmithKine
• Pfizer
• Johnson＆Johnson
• Heat Biologics
• Sanofi
Global Approved COVID-19 Vaccines Market: By Type
• Component Viral Vaccines
• Whole Virus Vaccines
Global Approved COVID-19 Vaccines Market: By Application
• Adults
• Children
• Elderly
Global Approved COVID-19 Vaccines Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Approved COVID-19 Vaccines market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
| Report Attribute/Metric | Details |
| Market Size 2021 | USD 6.25 Billion |
| Market Size 2030 | USD 10.79 Billion |
| Compound Annual Growth Rate (CAGR) | 7.16%(2023-2030) |
| Base Year | 2022 |
| Forecast Period | 2023-2032 |
| Historical Data | 2018-2022 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| By Type | • Component Viral Vaccines • Whole Virus Vaccines |
| By Application | • Adults • Children • Elderly |
| Key Companies Profiled | • Moderna • CanSino Biologicals • Inovio Pharmaceuticals • Shenzhen Geno-Immune Medical Institute • GlaxoSmithKine • Pfizer • Johnson＆Johnson • Heat Biologics • Sanofi |
| Regions and Key Countries Covered | U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America |
| Customization Scope | Available on Request |
Reasons to Purchase Approved COVID-19 Vaccines Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Overall, market research reports provide businesses and organizations with valuable information that can help them make informed decisions and stay competitive in their industry. They can provide a solid foundation for business planning, strategy development, and decision-making.
Objectives of Approved COVID-19 Vaccines Market Study:
The objectives of Approved COVID-19 Vaccines market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Approved COVID-19 Vaccines market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Overall, the objectives of Approved COVID-19 Vaccines market research report are to provide businesses and organizations with valuable insights and data-driven recommendations that can help them make informed business decisions and stay competitive in their industry.
Frequently Asked Questions
Approved COVID-19 Vaccines Market size was valued at USD 6.25 Billion in 2021 and is projected to reach USD 10.79 Billion by 2030, growing at a CAGR of 7.16% from 2023 to 2030.
Approved COVID-19 Vaccines are vaccines that have received regulatory authorization or full approval for use in preventing COVID-19.
Trends are driven by efforts to combat the pandemic, vaccine development speed, vaccine diversity, booster shots, global equity, and vaccination challenges.
Pediatric vaccination expands the eligible population for COVID-19 vaccination to include children and adolescents.
Ongoing research areas include vaccine duration of protection, mix-and-match vaccination, real-world effectiveness, and special populations.
TABLE OF CONTENT
1 Approved COVID-19 Vaccines Market Overview
1.1 Product Overview and Scope of Approved COVID-19 Vaccines
1.2 Approved COVID-19 Vaccines Segment by Type
1.2.1 Global Approved COVID-19 Vaccines Market Value Comparison by Type (2023-2029)
1.2.2 Component Viral Vaccines
1.2.3 Whole Virus Vaccines
1.3 Approved COVID-19 Vaccines Segment by Application
1.3.1 Global Approved COVID-19 Vaccines Market Value by Application: (2023-2029)
1.3.2 Adults
1.3.3 Children
1.3.4 Elderly
1.4 Global Approved COVID-19 Vaccines Market Size Estimates and Forecasts
1.4.1 Global Approved COVID-19 Vaccines Revenue 2017-2032
1.4.2 Global Approved COVID-19 Vaccines Sales 2017-2032
1.4.3 Global Approved COVID-19 Vaccines Market Average Price (2017-2032)
1.5 Assumptions and Limitations
2 Approved COVID-19 Vaccines Market Competition by Manufacturers
2.1 Global Approved COVID-19 Vaccines Sales Market Share by Manufacturers (2017-2023)
2.2 Global Approved COVID-19 Vaccines Revenue Market Share by Manufacturers (2017-2023)
2.3 Global Approved COVID-19 Vaccines Average Price by Manufacturers (2017-2023)
2.4 Global Approved COVID-19 Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Approved COVID-19 Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Approved COVID-19 Vaccines, Product Type & Application
2.7 Approved COVID-19 Vaccines Market Competitive Situation and Trends
2.7.1 Approved COVID-19 Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Approved COVID-19 Vaccines Players Market Share by Revenue
2.7.3 Global Approved COVID-19 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Approved COVID-19 Vaccines Retrospective Market Scenario by Region
3.1 Global Approved COVID-19 Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Approved COVID-19 Vaccines Global Approved COVID-19 Vaccines Sales by Region: 2017-2032
3.2.1 Global Approved COVID-19 Vaccines Sales by Region: 2017-2023
3.2.2 Global Approved COVID-19 Vaccines Sales by Region: 2023-2032
3.3 Global Approved COVID-19 Vaccines Global Approved COVID-19 Vaccines Revenue by Region: 2017-2032
3.3.1 Global Approved COVID-19 Vaccines Revenue by Region: 2017-2023
3.3.2 Global Approved COVID-19 Vaccines Revenue by Region: 2023-2032
3.4 North America Approved COVID-19 Vaccines Market Facts & Figures by Country
3.4.1 North America Approved COVID-19 Vaccines Market Size by Country: 2018 VS 2023 VS 2032
3.4.2 North America Approved COVID-19 Vaccines Sales by Country (2017-2032)
3.4.3 North America Approved COVID-19 Vaccines Revenue by Country (2017-2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Approved COVID-19 Vaccines Market Facts & Figures by Country
3.5.1 Europe Approved COVID-19 Vaccines Market Size by Country: 2018 VS 2023 VS 2032
3.5.2 Europe Approved COVID-19 Vaccines Sales by Country (2017-2032)
3.5.3 Europe Approved COVID-19 Vaccines Revenue by Country (2017-2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Approved COVID-19 Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Approved COVID-19 Vaccines Market Size by Country: 2018 VS 2023 VS 2032
3.6.2 Asia Pacific Approved COVID-19 Vaccines Sales by Country (2017-2032)
3.6.3 Asia Pacific Approved COVID-19 Vaccines Revenue by Country (2017-2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Approved COVID-19 Vaccines Market Facts & Figures by Country
3.7.1 Latin America Approved COVID-19 Vaccines Market Size by Country: 2018 VS 2023 VS 2032
3.7.2 Latin America Approved COVID-19 Vaccines Sales by Country (2017-2032)
3.7.3 Latin America Approved COVID-19 Vaccines Revenue by Country (2017-2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Approved COVID-19 Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Approved COVID-19 Vaccines Market Size by Country: 2018 VS 2023 VS 2032
3.8.2 Middle East and Africa Approved COVID-19 Vaccines Sales by Country (2017-2032)
3.8.3 Middle East and Africa Approved COVID-19 Vaccines Revenue by Country (2017-2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Approved COVID-19 Vaccines Sales by Type (2017-2032)
4.1.1 Global Approved COVID-19 Vaccines Sales by Type (2017-2023)
4.1.2 Global Approved COVID-19 Vaccines Sales by Type (2023-2032)
4.1.3 Global Approved COVID-19 Vaccines Sales Market Share by Type (2017-2032)
4.2 Global Approved COVID-19 Vaccines Revenue by Type (2017-2032)
4.2.1 Global Approved COVID-19 Vaccines Revenue by Type (2017-2023)
4.2.2 Global Approved COVID-19 Vaccines Revenue by Type (2023-2032)
4.2.3 Global Approved COVID-19 Vaccines Revenue Market Share by Type (2017-2032)
4.3 Global Approved COVID-19 Vaccines Price by Type (2017-2032)
5 Segment by Application
5.1 Global Approved COVID-19 Vaccines Sales by Application (2017-2032)
5.1.1 Global Approved COVID-19 Vaccines Sales by Application (2017-2023)
5.1.2 Global Approved COVID-19 Vaccines Sales by Application (2023-2032)
5.1.3 Global Approved COVID-19 Vaccines Sales Market Share by Application (2017-2032)
5.2 Global Approved COVID-19 Vaccines Revenue by Application (2017-2032)
5.2.1 Global Approved COVID-19 Vaccines Revenue by Application (2017-2023)
5.2.2 Global Approved COVID-19 Vaccines Revenue by Application (2023-2032)
5.2.3 Global Approved COVID-19 Vaccines Revenue Market Share by Application (2017-2032)
5.3 Global Approved COVID-19 Vaccines Price by Application (2017-2032)
6 Key Companies Profiled
6.1 Moderna
6.1.1 Moderna Corporation Information
6.1.2 Moderna Description and Business Overview
6.1.3 Moderna Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.1.4 Moderna Approved COVID-19 Vaccines Product Portfolio
6.1.5 Moderna Recent Developments/Updates
6.2 CanSino Biologicals
6.2.1 CanSino Biologicals Corporation Information
6.2.2 CanSino Biologicals Description and Business Overview
6.2.3 CanSino Biologicals Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.2.4 CanSino Biologicals Approved COVID-19 Vaccines Product Portfolio
6.2.5 CanSino Biologicals Recent Developments/Updates
6.3 Inovio Pharmaceuticals
6.3.1 Inovio Pharmaceuticals Corporation Information
6.3.2 Inovio Pharmaceuticals Description and Business Overview
6.3.3 Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.3.4 Inovio Pharmaceuticals Approved COVID-19 Vaccines Product Portfolio
6.3.5 Inovio Pharmaceuticals Recent Developments/Updates
6.4 Shenzhen Geno-Immune Medical Institute
6.4.1 Shenzhen Geno-Immune Medical Institute Corporation Information
6.4.2 Shenzhen Geno-Immune Medical Institute Description and Business Overview
6.4.3 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product Portfolio
6.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments/Updates
6.5 GlaxoSmithKine
6.5.1 GlaxoSmithKine Corporation Information
6.5.2 GlaxoSmithKine Description and Business Overview
6.5.3 GlaxoSmithKine Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.5.4 GlaxoSmithKine Approved COVID-19 Vaccines Product Portfolio
6.5.5 GlaxoSmithKine Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.6.4 Pfizer Approved COVID-19 Vaccines Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Johnson＆Johnson
6.6.1 Johnson＆Johnson Corporation Information
6.6.2 Johnson＆Johnson Description and Business Overview
6.6.3 Johnson＆Johnson Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Johnson＆Johnson Approved COVID-19 Vaccines Product Portfolio
6.7.5 Johnson＆Johnson Recent Developments/Updates
6.8 Heat Biologics
6.8.1 Heat Biologics Corporation Information
6.8.2 Heat Biologics Description and Business Overview
6.8.3 Heat Biologics Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.8.4 Heat Biologics Approved COVID-19 Vaccines Product Portfolio
6.8.5 Heat Biologics Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.9.4 Sanofi Approved COVID-19 Vaccines Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Approved COVID-19 Vaccines Industry Chain Analysis
7.2 Approved COVID-19 Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Approved COVID-19 Vaccines Production Mode & Process
7.4 Approved COVID-19 Vaccines Sales and Marketing
7.4.1 Approved COVID-19 Vaccines Sales Channels
7.4.2 Approved COVID-19 Vaccines Distributors
7.5 Approved COVID-19 Vaccines Customers
8 Approved COVID-19 Vaccines Market Dynamics
8.1 Approved COVID-19 Vaccines Industry Trends
8.2 Approved COVID-19 Vaccines Market Drivers
8.3 Approved COVID-19 Vaccines Market Challenges
8.4 Approved COVID-19 Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Approved COVID-19 Vaccines
1.2 Approved COVID-19 Vaccines Segment by Type
1.2.1 Global Approved COVID-19 Vaccines Market Value Comparison by Type (2023-2029)
1.2.2 Component Viral Vaccines
1.2.3 Whole Virus Vaccines
1.3 Approved COVID-19 Vaccines Segment by Application
1.3.1 Global Approved COVID-19 Vaccines Market Value by Application: (2023-2029)
1.3.2 Adults
1.3.3 Children
1.3.4 Elderly
1.4 Global Approved COVID-19 Vaccines Market Size Estimates and Forecasts
1.4.1 Global Approved COVID-19 Vaccines Revenue 2017-2032
1.4.2 Global Approved COVID-19 Vaccines Sales 2017-2032
1.4.3 Global Approved COVID-19 Vaccines Market Average Price (2017-2032)
1.5 Assumptions and Limitations
2 Approved COVID-19 Vaccines Market Competition by Manufacturers
2.1 Global Approved COVID-19 Vaccines Sales Market Share by Manufacturers (2017-2023)
2.2 Global Approved COVID-19 Vaccines Revenue Market Share by Manufacturers (2017-2023)
2.3 Global Approved COVID-19 Vaccines Average Price by Manufacturers (2017-2023)
2.4 Global Approved COVID-19 Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Approved COVID-19 Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Approved COVID-19 Vaccines, Product Type & Application
2.7 Approved COVID-19 Vaccines Market Competitive Situation and Trends
2.7.1 Approved COVID-19 Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Approved COVID-19 Vaccines Players Market Share by Revenue
2.7.3 Global Approved COVID-19 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Approved COVID-19 Vaccines Retrospective Market Scenario by Region
3.1 Global Approved COVID-19 Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Approved COVID-19 Vaccines Global Approved COVID-19 Vaccines Sales by Region: 2017-2032
3.2.1 Global Approved COVID-19 Vaccines Sales by Region: 2017-2023
3.2.2 Global Approved COVID-19 Vaccines Sales by Region: 2023-2032
3.3 Global Approved COVID-19 Vaccines Global Approved COVID-19 Vaccines Revenue by Region: 2017-2032
3.3.1 Global Approved COVID-19 Vaccines Revenue by Region: 2017-2023
3.3.2 Global Approved COVID-19 Vaccines Revenue by Region: 2023-2032
3.4 North America Approved COVID-19 Vaccines Market Facts & Figures by Country
3.4.1 North America Approved COVID-19 Vaccines Market Size by Country: 2018 VS 2023 VS 2032
3.4.2 North America Approved COVID-19 Vaccines Sales by Country (2017-2032)
3.4.3 North America Approved COVID-19 Vaccines Revenue by Country (2017-2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Approved COVID-19 Vaccines Market Facts & Figures by Country
3.5.1 Europe Approved COVID-19 Vaccines Market Size by Country: 2018 VS 2023 VS 2032
3.5.2 Europe Approved COVID-19 Vaccines Sales by Country (2017-2032)
3.5.3 Europe Approved COVID-19 Vaccines Revenue by Country (2017-2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Approved COVID-19 Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Approved COVID-19 Vaccines Market Size by Country: 2018 VS 2023 VS 2032
3.6.2 Asia Pacific Approved COVID-19 Vaccines Sales by Country (2017-2032)
3.6.3 Asia Pacific Approved COVID-19 Vaccines Revenue by Country (2017-2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Approved COVID-19 Vaccines Market Facts & Figures by Country
3.7.1 Latin America Approved COVID-19 Vaccines Market Size by Country: 2018 VS 2023 VS 2032
3.7.2 Latin America Approved COVID-19 Vaccines Sales by Country (2017-2032)
3.7.3 Latin America Approved COVID-19 Vaccines Revenue by Country (2017-2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Approved COVID-19 Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Approved COVID-19 Vaccines Market Size by Country: 2018 VS 2023 VS 2032
3.8.2 Middle East and Africa Approved COVID-19 Vaccines Sales by Country (2017-2032)
3.8.3 Middle East and Africa Approved COVID-19 Vaccines Revenue by Country (2017-2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Approved COVID-19 Vaccines Sales by Type (2017-2032)
4.1.1 Global Approved COVID-19 Vaccines Sales by Type (2017-2023)
4.1.2 Global Approved COVID-19 Vaccines Sales by Type (2023-2032)
4.1.3 Global Approved COVID-19 Vaccines Sales Market Share by Type (2017-2032)
4.2 Global Approved COVID-19 Vaccines Revenue by Type (2017-2032)
4.2.1 Global Approved COVID-19 Vaccines Revenue by Type (2017-2023)
4.2.2 Global Approved COVID-19 Vaccines Revenue by Type (2023-2032)
4.2.3 Global Approved COVID-19 Vaccines Revenue Market Share by Type (2017-2032)
4.3 Global Approved COVID-19 Vaccines Price by Type (2017-2032)
5 Segment by Application
5.1 Global Approved COVID-19 Vaccines Sales by Application (2017-2032)
5.1.1 Global Approved COVID-19 Vaccines Sales by Application (2017-2023)
5.1.2 Global Approved COVID-19 Vaccines Sales by Application (2023-2032)
5.1.3 Global Approved COVID-19 Vaccines Sales Market Share by Application (2017-2032)
5.2 Global Approved COVID-19 Vaccines Revenue by Application (2017-2032)
5.2.1 Global Approved COVID-19 Vaccines Revenue by Application (2017-2023)
5.2.2 Global Approved COVID-19 Vaccines Revenue by Application (2023-2032)
5.2.3 Global Approved COVID-19 Vaccines Revenue Market Share by Application (2017-2032)
5.3 Global Approved COVID-19 Vaccines Price by Application (2017-2032)
6 Key Companies Profiled
6.1 Moderna
6.1.1 Moderna Corporation Information
6.1.2 Moderna Description and Business Overview
6.1.3 Moderna Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.1.4 Moderna Approved COVID-19 Vaccines Product Portfolio
6.1.5 Moderna Recent Developments/Updates
6.2 CanSino Biologicals
6.2.1 CanSino Biologicals Corporation Information
6.2.2 CanSino Biologicals Description and Business Overview
6.2.3 CanSino Biologicals Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.2.4 CanSino Biologicals Approved COVID-19 Vaccines Product Portfolio
6.2.5 CanSino Biologicals Recent Developments/Updates
6.3 Inovio Pharmaceuticals
6.3.1 Inovio Pharmaceuticals Corporation Information
6.3.2 Inovio Pharmaceuticals Description and Business Overview
6.3.3 Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.3.4 Inovio Pharmaceuticals Approved COVID-19 Vaccines Product Portfolio
6.3.5 Inovio Pharmaceuticals Recent Developments/Updates
6.4 Shenzhen Geno-Immune Medical Institute
6.4.1 Shenzhen Geno-Immune Medical Institute Corporation Information
6.4.2 Shenzhen Geno-Immune Medical Institute Description and Business Overview
6.4.3 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product Portfolio
6.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments/Updates
6.5 GlaxoSmithKine
6.5.1 GlaxoSmithKine Corporation Information
6.5.2 GlaxoSmithKine Description and Business Overview
6.5.3 GlaxoSmithKine Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.5.4 GlaxoSmithKine Approved COVID-19 Vaccines Product Portfolio
6.5.5 GlaxoSmithKine Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.6.4 Pfizer Approved COVID-19 Vaccines Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Johnson＆Johnson
6.6.1 Johnson＆Johnson Corporation Information
6.6.2 Johnson＆Johnson Description and Business Overview
6.6.3 Johnson＆Johnson Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Johnson＆Johnson Approved COVID-19 Vaccines Product Portfolio
6.7.5 Johnson＆Johnson Recent Developments/Updates
6.8 Heat Biologics
6.8.1 Heat Biologics Corporation Information
6.8.2 Heat Biologics Description and Business Overview
6.8.3 Heat Biologics Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.8.4 Heat Biologics Approved COVID-19 Vaccines Product Portfolio
6.8.5 Heat Biologics Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.9.4 Sanofi Approved COVID-19 Vaccines Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Approved COVID-19 Vaccines Industry Chain Analysis
7.2 Approved COVID-19 Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Approved COVID-19 Vaccines Production Mode & Process
7.4 Approved COVID-19 Vaccines Sales and Marketing
7.4.1 Approved COVID-19 Vaccines Sales Channels
7.4.2 Approved COVID-19 Vaccines Distributors
7.5 Approved COVID-19 Vaccines Customers
8 Approved COVID-19 Vaccines Market Dynamics
8.1 Approved COVID-19 Vaccines Industry Trends
8.2 Approved COVID-19 Vaccines Market Drivers
8.3 Approved COVID-19 Vaccines Market Challenges
8.4 Approved COVID-19 Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
In Vitro Diagnostics Quality Control Market
Global In Vitro Diagnostics Quality Control Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Ileostomy Market
Global Ileostomy Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market
Global Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Human Papillomavirus Vaccine Market
Global Human Papillomavirus Vaccine Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hospital Acquired Pneumonia Drugs Market
Global Hospital Acquired Pneumonia Drugs Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast